Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization

被引:0
|
作者
Kuang, Donglin [1 ]
Zhang, Nan [1 ]
Zhang, Mengfan [1 ]
Li, Hao [1 ]
Han, Xinwei [1 ]
Ren, Jianzhuang [1 ]
Duan, Xuhua [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; drug-eluting bead transcatheter arterial chemoembolization; magnetic resonance imaging; margin enhancement; morphology; MICROVASCULAR INVASION; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC-TUMORS; ABLATION; CT; MR; MICROSPHERES; PREDICTION; SURVIVAL; CANCER;
D O I
10.3389/fonc.2023.957710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). MethodsFrom January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded. ResultsIn the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of >= 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05). ConclusionsPatients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
    Morishita, Asahiro
    Tani, Joji
    Nomura, Takako
    Takuma, Kei
    Nakahara, Mai
    Oura, Kyoko
    Tadokoro, Tomoko
    Fujita, Koji
    Shi, Tingting
    Yamana, Hiroki
    Matsui, Takanori
    Takata, Tadayuki
    Sanomura, Takayuki
    Nishiyama, Yoshihiro
    Himoto, Takashi
    Tomonari, Tetsu
    Moriya, Akio
    Senoo, Tomonori
    Takaguchi, Koichi
    Masaki, Tsutomu
    CANCERS, 2021, 13 (18)
  • [32] Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE)
    Mariko M. Nakano
    Akira Yamamoto
    Norifumi Nishida
    Masao Hamuro
    Shinichi Hamamoto
    Atsushi Jogo
    Etsuji Sohgawa
    Ken Kageyama
    Tetsuya Minami
    Yukio Miki
    Japanese Journal of Radiology, 2019, 37 : 543 - 548
  • [33] Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma
    Xie, Zhi-Bo
    Wang, Xiao-Bo
    Peng, Yu-Chong
    Zhu, Shao-Liang
    Ma, Liang
    Xiang, Bang-De
    Gong, Wen-Feng
    Chen, Jie
    You, Xue-Mei
    Jiang, Jing-Hang
    Li, Le-Qun
    Zhong, Jian-Hong
    HEPATOLOGY RESEARCH, 2015, 45 (02) : 190 - 200
  • [34] Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization
    Sasaki, Ryu
    Taura, Naota
    Miyazoe, Yuri
    Yamamichi, Shinobu
    Nakashiki, Suguru
    Yamashima, Mio
    Suehiro, Tomoyuki
    Honda, Takuya
    Shibata, Hidetaka
    Ozawa, Eisuke
    Miuma, Satoshi
    Akazawa, Yuko
    Miyaaki, Hisamitsu
    Matsumoto, Takehiro
    Nakao, Kazuhiko
    Ashizawa, Kazuto
    NUTRITION, 2018, 50 : 97 - 103
  • [35] Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival
    Hien, Phan Nhan
    Chun, Ho Jong
    Oh, Jung Suk
    Kim, Su Ho
    Choi, Byung Gil
    ONCOLOGY, 2024, 102 (10) : 850 - 857
  • [36] Safety and Feasibility of Same-day Discharge of Patients with Unresectable Hepatocellular Carcinoma Treated with Doxorubicin Drug-eluting Bead Transcatheter Chemoembolization
    Prajapati, Hasmukh J.
    Rafi, Shoaib
    El-Rayes, Bassel F.
    Kauh, John S.
    Kooby, David A.
    Kim, Hyun S.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 23 (10) : 1286 - 1293
  • [37] Comparison of treatment response, survival and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres versus conventional transarterial chemoembolization in treating hepatocellular carcinoma
    Zhao, Chang
    Pei, Shenglin
    Chen, Zuyi
    Ma, Yilong
    JOURNAL OF BUON, 2019, 24 (03): : 1150 - 1166
  • [38] Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model
    Zhang, Xueying
    He, Zijun
    Zhang, Yucong
    Kong, Jian
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [39] Switching the Loaded Agent from Epirubicin to Cisplatin: Salvage Transcatheter Arterial Chemoembolization with Drug-eluting Microspheres for Unresectable Hepatocellular Carcinoma
    Seki, Akihiko
    Hori, Shinich
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 35 (03) : 555 - 562
  • [40] Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation
    Nicolini, Daniele
    Svegliati-Baroni, Gianluca
    Candelari, Roberto
    Mincarelli, Cinzia
    Mandolesi, Alessandra
    Bearzi, Italo
    Mocchegiani, Federico
    Vecchi, Andrea
    Montalti, Roberto
    Benedetti, Antonio
    Risaliti, Andrea
    Vivarelli, Marco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (34) : 5622 - 5632